Binxian Wei

CIK: 0001773586

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PALI

PALISADE BIO, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

PALI
PALISADE BIO, INC.
Jun 10, 2026
Award(A)
Direct
592.3K shares-
PALI
PALISADE BIO, INC.
Jun 10, 2026
Exercise(M)
Direct
20.2K shares-
PALI
PALISADE BIO, INC.
Oct 6, 2025
Award(A)
Restricted Stock Units
Direct
60.6K shares-
PALI
PALISADE BIO, INC.
Oct 6, 2025
Award(A)
Restricted Stock Units
Direct
510.7K shares-
PALI
PALISADE BIO, INC.
Sep 4, 2025
Award(A)
Phantom Units
Direct
18.8K shares-
PALI
PALISADE BIO, INC.
Nov 21, 2024
Exercise(M)
Direct
388 shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	PALI PALISADE BIO, INC.	Award(A)	592,300	-	$0	Direct
Jun 10, 2026	PALI PALISADE BIO, INC.	Exercise(M)	20,200	-	$0	Direct
Oct 6, 2025	PALI PALISADE BIO, INC.	Award(A) Restricted Stock Units	60,600	-	-	Direct
Oct 6, 2025	PALI PALISADE BIO, INC.	Award(A) Restricted Stock Units	510,700	-	-	Direct
Sep 4, 2025	PALI PALISADE BIO, INC.	Award(A) Phantom Units	18,800	-	-	Direct
Nov 21, 2024	PALI PALISADE BIO, INC.	Exercise(M)	388	-	$0	Direct

1-6 of 6 transactions

About Wei Binxian

Wei Binxian (SEC CIK 0001773586) files insider reports with the SEC as Director of PALISADE BIO, INC. (PALI).

Signal8 holds 5 ownership filings by Wei Binxian, all Form 4s, filed between Nov 22, 2024 and Jun 12, 2026. Those filings report 6 transactions, from Nov 21, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wei Binxian's filings is in DENVER, CO.

Recent filings by Wei Binxian

Jun 10, 2026: Grant or award of PALI shares (Form 4, code A).
Jun 10, 2026: Option exercise of PALI shares (Form 4, code M).
Oct 6, 2025: Grants or awards of PALI derivative securities (2 lines, Form 4, code A).
Sep 4, 2025: Grant or award of PALI derivative securities (Form 4, code A).
Nov 21, 2024: Option exercise of PALI shares (Form 4, code M).

Other insiders filing for PALISADE BIO, INC. (PALI)

How to read Form 4 transaction codes